maresin 1
Selected indexed studies
- Maresin-1 and Inflammatory Disease. (Int J Mol Sci, 2022) [PMID:35163291]
- Maresin-1 resolution with RORα and LGR6. (Prog Lipid Res, 2020) [PMID:32360520]
- Maresin-1 and its receptors RORα/LGR6 as potential therapeutic target for respiratory diseases. (Pharmacol Res, 2022) [PMID:35781060]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Maresin-1 and Inflammatory Disease. (2022) pubmed
- Maresin-1 resolution with RORα and LGR6. (2020) pubmed
- Maresin-1 and its receptors RORα/LGR6 as potential therapeutic target for respiratory diseases. (2022) pubmed
- Maresin 1 promotes nerve regeneration and alleviates neuropathic pain after nerve injury. (2022) pubmed
- Satellite glial GPR37L1 and its ligand maresin 1 regulate potassium channel signaling and pain homeostasis. (2024) pubmed
- Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions. (2023) pubmed
- Maresin-1 ameliorates hypertensive vascular remodeling through its receptor LGR6. (2024) pubmed
- Maresin-1 Ameliorates Sepsis-Induced Microglial Activation Through Modulation of the P38 MAPK Pathway. (2024) pubmed
- The Maresin 1-LGR6 axis decreases respiratory syncytial virus-induced lung inflammation. (2023) pubmed
- Maresin 1 activates brown adipose tissue and promotes browning of white adipose tissue in mice. (2023) pubmed